The study, published in BMC Neuroscience by a team at Xi’an Jiaotong University led by corresponding author Shiquan Sun, generated single-nucleus RNA sequencing data from adult mouse brains under deliberately varied experimental designs. Rather than testing one variable at a time in isolation, the researchers dissected the individual and interactive effects of three major workflow choices: whether tissue was harvested post-mortem or in vivo, whether nuclei were fixed in methanol or left fresh, and whether the library was sequenced on the widely used 10x Genomics platform or the SeekOne digital droplet system. Each of these decisions is made routinely in labs around the world, often with little consideration of how they might reshape the final dataset.

The most striking finding concerns the standard post-mortem harvest, the default approach in most single-nucleus studies because it is technically simpler than extracting nuclei from living tissue. The researchers found that post-mortem collection triggers a rapid and selective loss of metabolically active glutamatergic neuron subpopulations, the excitatory neurons that form the backbone of cortical computation. This loss is not a uniform shrinkage of all cell types; it preferentially eliminates specific vulnerable subpopulations, meaning the resulting cell composition no longer faithfully reflects the living brain. Intriguingly, the global transcriptome appeared largely preserved, which means the damage can hide beneath standard quality-control metrics that look only at overall gene detection.

That selective vulnerability carries a troubling implication for brain atlases. The study reports that while the global transcriptomic profile survives the post-mortem interval, transcripts related to advanced cognitive functions become obscured. In other words, a researcher comparing healthy and diseased brains might attribute differences in cognition-related gene expression to disease, when in fact the differences stem from how long the tissue sat before nuclei were extracted. Because glutamatergic neurons are central to nearly every model of cortical function, from memory circuits to the excitatory-inhibitory balance implicated in autism and schizophrenia, their disproportionate sensitivity to harvest stress is a bias that no atlas builder can afford to ignore.

The second variable the team examined was fixation. Methanol fixation is popular because it stabilizes samples for shipping and storage, allowing labs to process tissue collected at distant sites and to pause experiments mid-workflow. The benchmarking showed that methanol fixation minimally altered cell-type compositions, which is reassuring for anyone worried that the chemical treatment might preferentially destroy certain nuclei. However, the treatment was not transcriptionally neutral. It introduced cell-type-specific gene expression shifts, preferentially stabilizing structural and core functional transcripts in both neurons and glia. The practical consequence is that the measured abundance of particular genes depends on whether the sample was fixed, even when the underlying biology is identical.

Perhaps the most consequential discovery, however, involves the sequencing platform itself, a variable most researchers assume is merely a matter of cost and throughput. The team found that platform choice shaped biological interpretation in a profound way: the 10x Genomics and SeekOne digital droplet platforms captured largely non-overlapping differential expression signatures in response to harvest stress. When the same biological perturbation was profiled on the two systems, each platform reported a different set of genes as changing. The 10x platform showed a bias toward detecting synaptic transcript degradation, while SeekOne leaned toward preserved metabolic and glial programs. Two labs studying the same question with the same tissue could therefore reach substantively different molecular conclusions based on platform alone.

This platform dependence strikes at the heart of the reproducibility crisis in single-cell genomics. Large-scale initiatives, including efforts to build comprehensive cell atlases of the human and mouse brains, aggregate data generated on different instruments and with different preservation protocols. If the differential expression signatures triggered by a stressor are largely platform-specific, then integrating datasets without accounting for these effects risks conflating technical artifacts with genuine biological signal. The study’s authors argue that platform choice must be treated as a critical, non-neutral variable rather than an interchangeable commodity, and that meta-analyses should model platform effects explicitly rather than assuming they wash out in large datasets.

To separate artifact from biology, the researchers deployed a battery of quantitative benchmarks. Their evaluation toolkit included clustering concordance measures such as the Adjusted Rand Index and Normalized Mutual Information, cell-type separation metrics like the cell-type average silhouette width, and integration diagnostics including batch silhouette widths and Local Inverse Simpson’s Index variants that quantify how well cell types mix or remain distinct after computational integration. By applying these metrics across the factorial experimental designs, the team could attribute specific distortions to specific workflow steps. This framework, they emphasize, is not just a catalog of problems but a practical recipe: it gives other labs a way to audit their own pipelines and to design studies in which technical variables are measured and controlled rather than left unexamined.

The study also maps the cellular geography of vulnerability in fine detail. Drawing on established brain cell taxonomy, the team characterized glutamatergic neuron subclasses including intratelencephalic and extratelencephalic projecting cortical neurons, layer 6b near-projecting corticothalamic neurons, dentate gyrus immature glutamatergic neurons, and glutamatergic populations of the hypothalamus, thalamus, and midbrain, alongside GABAergic neurons, oligodendrocyte lineage cells, and astrocyte-ependymal cells. This granularity matters because the selective loss of metabolically active glutamatergic subpopulations is not visible at the level of broad cell classes. An analysis that lumps all excitatory neurons together would miss the fact that particular subclasses are disappearing, and with them the transcripts that define their specialized functions.

For the field at large, the message is a call for radical transparency in methods reporting. The authors conclude that precise reporting and control of workflow variables are prerequisites for accurate biological discovery in single-cell transcriptomics, particularly as the community moves toward integrative brain cell atlases meant to serve as durable community resources. Journals and consortia increasingly demand detailed metadata, and this study supplies a concrete reason why: harvest method, fixation chemistry, and sequencing platform each leave measurable fingerprints on the data, and those fingerprints can masquerade as biology. Until such variables are standardized or explicitly modeled, the researchers warn, differences between datasets should be interpreted with caution, and claims of disease-related or experience-related transcriptional changes in the brain should be validated across harvest conditions and platforms before being accepted as fact.

Subject of Research: Technical biases in single-nucleus RNA sequencing of the mouse brain

Article Title: A systematic multi-factorial benchmarking reveals critical technical biases in single-nucleus RNA sequencing of the brain

Article References: A systematic multi-factorial benchmarking reveals critical technical biases in single-nucleus RNA sequencing of the brain. (n.d.). https://doi.org/10.1186/s12868-026-01058-7

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01058-7

Keywords: single-nucleus RNA-seq, benchmarking, brain cell atlas, glutamatergic neurons, post-mortem harvest, methanol fixation, sequencing platform bias, 10x Genomics, SeekOne, transcriptomics, neuroscience, reproducibility

The technical centerpiece of the study is a method the team calls STICR, a lentiviral barcoding system that stamps progenitor cells with unique heritable DNA sequences. When a barcoded progenitor divides, all of its descendants carry the same genetic tag, allowing researchers to reconstruct family trees long after development has moved on. By injecting the virus at a series of embryonic and postnatal timepoints—from embryonic day 11 through postnatal day 0—and collecting tissue at postnatal day 4, the team captured clones born during distinct developmental windows. Each labeled cell was then profiled with single-cell RNA sequencing, and its barcode was read out alongside its transcriptome, linking identity to ancestry in a single measurement.

Knowing what a cell is, however, is only half the story; knowing where it sits is equally important. To anchor their lineage data in anatomy, the researchers used MERFISH, a spatial transcriptomics method that maps thousands of genes across intact coronal sections of the forebrain. By registering the cellular profiles recovered from dissociated tissue onto these spatial maps, the team could ask not only which cell types share a common ancestor, but also how far those relatives traveled from one another. The result is a spatiotemporal clonal atlas: a record of lineage, identity and location woven together across the entire newborn forebrain rather than a single privileged region such as the cortex, which has dominated most prior lineage studies.

The scale of the dataset allowed the authors to run careful computational checks on their inferences. Because viral labeling captures only a fraction of cells, the team built simulation frameworks using ground-truth clones to model how partial sampling affects the recovery of lineage structure. These simulations, described in the paper’s extended data, quantified how many multicellular clones are needed to reliably detect the constituent cell types of a lineage and how often apparent fate biases could arise by chance. Such validation matters, because the study’s headline conclusions rest on statistical patterns of clone sharing between cell types rather than on direct observation of dividing cells.

Among the most consequential findings is a new view of the striatum, the brain’s major input hub for movement and reward. The atlas reveals previously unrecognized differences in how ventral and dorsal medium spiny neurons—the principal projection neurons of the striatum—are generated. It also uncovers lineage relationships that had gone unexplored: late-born medium spiny neurons share clonal ancestry with striatal astrocytes and with distinct subpopulations of olfactory bulb neurons. This connects the striatum’s developmental program to the continuous postnatal production of neurons that migrate into the olfactory bulb, a hallmark of the subventricular zone that has long fascinated neuroscientists studying adult neurogenesis.

The broader principle that emerges from the atlas is a tale of two lineages. Glutamatergic neurons—the forebrain’s excitatory workhorses—and astrocytes, the star-shaped glial cells that support synapses, are clonally related to one another and remain within their region of origin. A clone born in the cortex stays in the cortex; one born in the hippocampus stays in the hippocampus. GABAergic neurons, the inhibitory counterpart, follow a different rule. They are clonally linked to oligodendrocyte precursor cells, the myelin-forming lineage, and they disperse extensively, crossing regional and structural boundaries. The findings echo and extend earlier work showing that clonally related interneurons spread widely across the forebrain, but the new atlas places that dispersal within a whole-brain framework and ties it to glial fate.

That dispersal carries a provocative clinical hint. The researchers found that clones of GABAergic neurons with broad regional dispersion are enriched for genes implicated in neurodevelopmental disorders, including genes associated with autism. In other words, the cell lineages most likely to spread across the brain are also the ones whose genetic programs intersect most heavily with disease risk. This observation suggests that disruptions to widely dispersing inhibitory lineages could have consequences distributed across multiple brain regions, offering a potential developmental framework for understanding why genetic risk factors for neurodevelopmental conditions produce such varied and widespread effects.

The temporal dimension of the atlas adds further texture. By comparing clones labeled at different embryonic and postnatal stages, the team traced how lineage composition shifts over time: early-labeled clones are dominated by deep-layer cortical neurons, while later windows capture upper-layer neurons, glia and the postnatally generated populations destined for the olfactory bulb. In the olfactory bulb itself, the data distinguish embryonically or locally generated GABAergic neurons from postnatally born neurons still migrating through the rostral migratory stream at the time of collection. Cajal–Retzius cells, the pioneer neurons that guide cortical layering, also appear in the atlas with their own regionally specific lineage relationships to astrocytes and ependymal cells.

Methodologically, the study demonstrates how viral barcoding, single-cell transcriptomics and spatial transcriptomics can be fused into a single coherent picture of organ-scale development. The authors have made their resources broadly available: the single-cell and barcode datasets are deposited in the Gene Expression Omnibus under accession GSE341480, an interactive browser of the single-cell and MERFISH data is hosted through the UCSC cell browser, the image dataset is available through the Brain Image Library, and the custom analysis code is published on GitHub. For a field increasingly reliant on large-scale atlases, this openness means other laboratories can immediately interrogate the lineage relationships, test alternative hypotheses and integrate the data with their own developmental and disease-focused studies.

The implications reach well beyond the mouse. Human studies have suggested that individual cortical progenitors can produce both excitatory and inhibitory neurons, and the new mouse atlas provides a mechanistic reference against which human lineage data can be interpreted. By establishing that lineage fate—whether a progenitor’s descendants become neurons, astrocytes or oligodendrocyte precursor cells—is governed by regionally specific rules that differ fundamentally between excitatory and inhibitory lineages, the work offers a foundational framework for dissecting how the mammalian forebrain is assembled, and how that assembly goes awry in disease. As the authors note, the atlas is intended as a reference point for the field: a first whole-forebrain census of who is related to whom, where they ended up, and when they were born.

Subject of Research: Clonal lineage relationships and cell fate specification during mouse forebrain development

Article Title: Spatiotemporal clonal architecture of the newborn mouse forebrain

Article References: Yuan, G., Kunst, M., Steyert, M. R., Keefe, M. G., Mathieu, R., van Velthoven, C. T. J., McMillen, D., Waters, J., Fukushima, Y., Kazerounian, A., Alvarez-Buylla, A., Zeng, H., & Nowakowski, T. J. (2026). Spatiotemporal clonal architecture of the newborn mouse forebrain. Nature. https://doi.org/10.1038/s41586-026-11064-8

Image Credits: AI Generated

DOI: 10.1038/s41586-026-11064-8

Keywords: mouse forebrain, clonal lineage, lentiviral barcoding, spatial transcriptomics, MERFISH, single-cell RNA sequencing, GABAergic neurons, glutamatergic neurons, astrocytes, oligodendrocyte precursor cells, neurodevelopmental disorders, striatum